Theriva Biologics, Inc. - TOVX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$264K
QoQ value delta ($000)
+$91K (+52.6%)
Implied price effect (QoQ)
-48.52%
Shares
Total shares
1,295,508
QoQ shares delta
+858,453 (+196.42%)
Total shares held by funds (by quarter)

Market chart (TOVX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 53 255,727 0.0%
GEODE CAPITAL MANAGEMENT, LLC 44 212,087 0.0%
MORGAN STANLEY 42 200,000 0.0%
UBS Group AG 40 191,410 0.0%
Ikarian Capital, LLC 23 112,076 0.0%
TWO SIGMA SECURITIES, LLC 9 42,893 0.0%
TWO SIGMA INVESTMENTS, LP 8 42,337 0.0%
DRW Securities, LLC 8 41,745 0.0%
XTX Topco Ltd 8 39,445 0.0%
StoneX Group Inc. 7 37,217 0.0%
BANK OF AMERICA CORP /DE/ 6 31,139 0.0%
BARCLAYS PLC 6 32,569 0.0%
BOOTHBAY FUND MANAGEMENT, LLC 5 27,646 0.0%
SCHWARZ DYGOS WHEELER INVESTMENT ADVISORS LLC 3 15,000 0.0%
CITIGROUP INC 1 6,189 0.0%
BlackRock, Inc. 1 7,504 0.0%
DANSKE BANK A/S 0 1 0.0%
IFP Advisors, Inc 0 11 0.0%
OSAIC HOLDINGS, INC. 0 448 0.0%
SBI Securities Co., Ltd. 0 59 0.0%
Newbridge Financial Services Group, Inc. 0 5 0.0%